 |
|
Effect of abatacept versus conventional synthetic disease modifying anti-rheumatic drugs on rheumatoid arthritis-associated interstitial lung disease
Kyung-Ann Lee, Bo Young Kim, Sung Soo Kim, Yun Hong Cheon, Sang-Il Lee, Sang-Hyon Kim, Jae Hyun Jung, Geun-Tae Kim, Jin-Wuk Hur, Myeung-Su Lee, Yun Sung Kim, Seung-Jae Hong, Suyeon Park, Hyun-Sook Kim
Korean J Intern Med. 2024;39(5):855-864. Published online 2024 Aug 30 DOI: https://doi.org/10.3904/kjim.2023.207
|
|
Citations to this article as recorded by
 Impact of csDMARDs vs. b/tsDMARDs on the Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multicenter, Retrospective Study
Kyung-Ann Lee, Bo Young Kim, Sung Soo Kim, Yun Hong Cheon, Sang-Hyon Kim, Jae Hyun Jung, Geun-Tae Kim, Jin-Wuk Hur, Myeung-Su Lee, Chong Hyuk Chung, Yun Sung Kim, Seung-Jae Hong, Hae-Rim Kim, Hong Ki Min, Se Hee Kim, Su-Jin Moon, Sung Hae Chang, Soojin Im
Diagnostics.2025; 15(7): 800. CrossRef Folate Receptor-Mediated Targeting Strategies for Potential Management & Treatment of Rheumatoid Arthritis
Afifa Shafiq, Hassan Shah, Aslam Khan, Safiullah Khan, Faizan Akram, Mamuna Shafique, Faisal Sattar, Muhammad Farhan Hanif, Muhammad Saad Hashmat, Asadullah Madni
Journal of Drug Delivery Science and Technology.2025; : 106916. CrossRef Hydroxychloroquine/Methotrexate/Sulfasalazine
Reactions Weekly.2024; 2030(1): 221. CrossRef
|